MEDGX Fees and Costs — MFS Emerging Markets Debt Fund, Class R4
Data updated: 2026-10-13
The net expense ratio is 0.82%: a 0.67% management fee plus 0.16% other expenses, less a 0.01% fee waiver. There are no sales loads or redemption fees. In fiscal 2026 the fund paid $256K in broker commissions, 0.0034% of average net assets, and portfolio turnover was 69%.
MEDGX Fees and Expenses
Annual operating expenses and sales charges of MEDGX. Prospectus, as of July 31, 2025.
| Annual operating expenses | |
|---|---|
| Management fee | 0.67% |
| 12b-1 fee | 0.00% |
| Other expenses | 0.16% |
| Gross expense ratio | 0.83% |
| Fee waiver | −0.01% |
| Net expense ratio | 0.82% |
| Sales charges | |
|---|---|
| Max front load | 0.00% |
| Max deferred load | 0.00% |
| Redemption fee | — |
MEDGX Costs Over Time
On $10,000 invested in MEDGX, assuming 5% a year before costs, total costs come to $517 over 5 years, cutting the return by 0.86% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.82%) | $86 | $269 | $468 |
| Trading costs (broker commissions) | $0 | $1 | $2 |
| Lost growth on money paid in costs | $0 | $13 | $47 |
| Total costs | $86 | $284 | $517 |
| Value after costs | $10,414 | $11,293 | $12,246 |
| Impact on return, per year | 0.86% | 0.86% | 0.86% |
MEDGX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending July 31, 2026.
- Explicit cost rate (commissions ÷ average net assets): 0.0034%
- Total broker commissions: $256K
- Bought from dealers (principal trades, not a cost): $12.2B
- Portfolio turnover (prospectus): 69%
MEDGX Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| BofA Securities, Inc. | $256K | 100.00% |
| Barclays Capital Inc. | $4 | 0.00% |
MEDGX Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| BNY Capital Markets, LLC | $1.8B | 17.85% |
| Citigroup Global Markets Inc. | $1.7B | 16.76% |
| J.P. Morgan Securities LLC | $1.3B | 12.78% |
| Goldman Sachs & Co. LLC | $1.2B | 12.27% |
| HSBC Securities (USA) Inc. | $1.0B | 10.14% |
| Morgan Stanley & Co. LLC | $641.7M | 6.47% |
| Barclays Capital Inc. | $635.4M | 6.41% |
| BofA Securities, Inc. | $633.3M | 6.39% |
| Jefferies LLC | $598.5M | 6.04% |
| Santander Securities LLC | $484.6M | 4.89% |
MFS Emerging Markets Debt Fund Share Classes
Net expense ratio and maximum front-end load of each share class, cheapest first.
| Ticker | Class | Net expense ratio | Front load |
|---|---|---|---|
| MEDHX | Class R6 | 0.71% | none |
| MEDGX | Class R4 | 0.82% | none |
| MEDIX | Class I | 0.82% | none |
| MEDAX | Class A | 1.07% | 4.25% |
| MEDFX | Class R3 | 1.07% | none |
| MEDEX | Class R2 | 1.32% | none |
| MEDBX | Class B | 1.82% | none |
| MEDCX | Class C | 1.82% | none |
| MEDDX | Class R1 | 1.82% | none |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.